Kayla Stoick, PA
Physician Assistant · Englewood, CONPI 1427539626
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,952 of the $23,097 with a category attached, or 82.1%. It is spread thinly across 35 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $10,740, more than ten times the $1,040 reported in 2021. Among physician assistant clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 672 payments — averaging $34.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$3K
- Genentech USA, Inc.$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Ardelyx, Inc.$1K
- plus $9K from 29 others
What the payments were for
- Consulting fees$2,93013%
- Speaking & faculty fees$3401%
- Travel & lodging$7893%
- Food & beverage$18,95282%
- Education$850%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 161 | $4,342 |
| Johnson & Johnson | 39 | $3,087 |
| Genentech USA, Inc. | 5 | $2,663 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 80 | $1,787 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $1,344 |
| Ardelyx, Inc. | 24 | $1,267 |
| Gilead | 38 | $1,152 |
| Sanofi | 31 | $1,080 |
| Lilly USA, LLC | 29 | $920 |
| Ipsen Biopharmaceuticals, Inc | 16 | $653 |
| Aimmune Therapeutics, Inc. | 20 | $633 |
| QOL Medical, LLC | 29 | $537 |
| Regeneron Healthcare Solutions, Inc. | 21 | $470 |
| Bristol Myers Squibb | 28 | $467 |
| Novo Nordisk | 6 | $409 |
| Intercept Pharmaceuticals, Inc. | 20 | $380 |
| Axonics, Inc. | 2 | $208 |
| Madrigal Pharmaceuticals | 3 | $185 |
| Mirum Pharmaceuticals, Inc. | 3 | $177 |
| Ironwood Pharmaceuticals, Inc | 9 | $167 |
| Amgen | 2 | $156 |
| Ferring Pharmaceuticals Inc. | 9 | $153 |
| Pfizer | 9 | $135 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Phathom Pharmaceuticals, Inc. | 8 | $117 |
| Boehringer Ingelheim | 5 | $116 |
| Organon | 7 | $90 |
| Braintree Laboratories, Inc. | 6 | $83 |
| Celltrion USA Inc. | 1 | $41 |
| Genentech, Inc. | 1 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $33 |
| Enterra Medical, Inc. | 1 | $27 |
| Mylan Institutional Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Orphalan Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,097 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 21 | $54,013 |
| XifaxanRifaximin | 16 | $39,703 |
| LinzessLinaclotide | 38 | $37,700 |
| Mesalamine | 36 | $9,534 |
| Omeprazole | 482 | $8,805 |
| TrulancePlecanatide | 14 | $8,797 |
| Dexlansoprazole DrDexlansoprazole | 16 | $6,440 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 33 | $5,421 |
| Colestipol Hcl | 44 | $5,187 |
| Budesonide DrBudesonide | 42 | $4,062 |
| Famotidine | 177 | $2,977 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 23 | $2,901 |
| Azathioprine | 27 | $2,411 |
| Vancomycin Hcl | 14 | $1,932 |
| Dicyclomine Hcl | 101 | $1,580 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $4,342 | $91,71359 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $1,787 | $48,50130 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $83 | $8,32356 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Englewood
- Donald MooreEnglewood$246K
- Kathryn HarrisonEnglewood$12K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
- Emily FrischDenver$79K
- Daniel HumerLone Tree$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.